.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Abstract talk
O 001

Class switching towards IgG2 and IgG4 is more elevated in individuals who received the BNT162b2 vaccine compared to those who received the mRNA-1273 COVID-19 vaccine.

Appointment

Date: 04/03/2025

Time: 16:00 – 16:15

Talk time: 12 Min.

Discussion time: 3 Min.

Location / Stream:

Audimax II

Session

Viral vectors and vaccines I

Topic

Viral vectors and vaccines

Authors

Alex S. Siebner (Tuebingen / DE), Dr. Kelsey E. Huus (Tuebingen / DE), Johanna Griesbaum (Reutlingen / DE), Judith Flügge (Tuebingen / DE), Professor Kristina Hopfensperger (Tuebingen / DE), Dr. Tanja Michel (Reutlingen / DE), Dr. Nicole Schneiderhan-Marra (Reutlingen / DE), Prof. Dr. Daniel Sauter (Tuebingen / DE), Prof. Dr. Peter G. Kremsner (Lambaréné / GA; Tuebingen / DE), Prof. Dr. Ruth E. Ley (Tuebingen / DE), Dr. Alex Dulovic (Reutlingen / DE), Dr. Meral Esen (Lambaréné / GA; Tuebingen / DE)